Rapid and sensitive allele-specific (AS)-RT-PCR assay for detection of T315I mutation in chronic myeloid leukemia patients treated with tyrosine-kinase inhibitors

Author： Manrique Arechavaleta Gonzalo   Scholl Vanesa   Pérez Verónica   Bittencourt Roberta   Moellmann Arthur   Hassan Rocio   Seuánez Héctor   Dobbin Jane   Martinez Lem   Renault Ilana   Uriarte Rosario  

Publisher： Springer Publishing Company

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.11, Iss.1, 2011-03, pp. : 55-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 2050-2051

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 2050-2051

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3894-3904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 270-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-06 ,pp. : 192-195

Karger

Access to resources Recommend Favorite